Artrya Ltd has released a press release.
Artrya Lodges Key Submission in FDA Process
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Artrya
- Quarterly Activity Report and Appendix 4C-March 2023
- Board and Management Changes
- Appendix 4D and Half Year Financial Report
- Artrya Gains UK Regulatory Approval
- Artrya Successful in Gaining European Regulatory Approval
Later from Artrya
- AYA Conducts Successful Q-Submission Meeting with FDA
- Company Presentation - MST Digital Health Forum
- Quarterly Activity Report and Appendix 4C-June 2023
- Appendix 4E and Annual Financial Report - 30 June 2023
- Quarterly Activity Report and Appendix 4C
Follow Artrya into a list and get an email when it puts out news.
Follow Artrya